A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Active Psoriatic Arthritis Date Posted: June 27, 2018IRB #: IRB00151158Principal Investigator:Ana-Maria Orbai, MD, MHS[…]
